Page 935 - Williams Hematology ( PDFDrive )

910 Part VI: The Erythrocyte Chapter 58: The Porphyrias 911

50. Jaffe EK, Stith L: ALAD porphyria is a conformational disease. Am J Hum Genet 81. Porra RJ, Jones OT: Studies on ferrochelatase. 1. Assay and properties of ferrochelatase
80(2):329, 2007. from a pig-liver mitochondrial extract. Biochem J 87:181, 1963.
51. Battersby AR, Fookes CJ, Matcham GW, et al: Biosynthesis of the pigments of life: 82. Whitcombe DM, Carter NP, Albertson DG, et al: Assignment of the human ferroche-
Formation of the macrocycle. Nature 285(5759):17, 1980. latase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics
52. Jordan PM: The biosynthesis of 5-aminolevulinic acid and its transformation into 11(4):1152, 1991.
coproporphyrinogen in animals and bacteria, in Biosynthesis of Heme and Chloro- 83. Medlock A, Swartz L, Dailey TA, et al: Substrate interactions with human ferrochela-
phylls, edited by Dailey HA, p 55. McGraw-Hill, New York, 1990. tase. Proc Natl Acad Sci U S A 104(6):1789, 2007.
53. Awan SJ, Siligardi G, Shoolingin-Jordan PM, et al: Reconstitution of the holoenzyme 84. Medlock AE, Dailey TA, Ross TA, et al: A pi-helix switch selective for porphyrin
form of Escherichia coli porphobilinogen deaminase from apoenzyme with porpho- deprotonation and product release in human ferrochelatase. J Mol Biol 373(4):1006,
bilinogen and preuroporphyrinogen: A study using circular dichroism spectroscopy. 2007.
Biochemistry 36(30):9273, 1997. 85. Wada O, Sassa S, Takaku F, et al: Different responses of the hepatic and erythropoietic
54. Wang AL, Arredondo-Vega FX, Giampietro PF, et al: Regional gene assignment of delta-aminolevulinic acid synthetase of mice. Biochim Biophys Acta 148(2):585, 1967.
human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 86. Sassa S, Nagai T: The role of heme in gene expression. Int J Hematol 63(3):167, 1996.
11qter. Proc Natl Acad Sci U S A 78(9):5734, 1981. 87. Erwin A, Balwani M, Desnick RJ: Congenital Erythropoietic Porphyria. University of
55. Chretien S, Dubart A, Beaupain D, et al: Alternative transcription and splicing of the Washington, Seattle, 2013.
human porphobilinogen deaminase gene result either in tissue-specific or in house- 88. Sassa S, Akagi R, Nishitani C, et al: Late-onset porphyrias: What are they? Cell Mol Biol
keeping expression. Proc Natl Acad Sci U S A 85(1):6, 1988. (Noisy-le-grand) 48(1):97, 2002.
56. Grandchamp B, De Verneuil H, Beaumont C, et al: Tissue specific expression of por- 89. Fritsch C, Bolsen K, Ruzicka T, et al: Congenital erythropoietic porphyria. J Am Acad
phobilinogen deaminase. Two isoenzymes from a single gene. Eur J Biochem 162:105, Dermatol 36(4):594, 1997.
1987. 90. Günther H: in Handbuch der Krankheiten der Blutes und der Blutbildenden Organe, vol
57. Raich N, Romeo PH, Dubart A, et al: Molecular cloning and complete primary 2, edited by Schittenhelm A. Springer-Verlag, Berlin, 1925.
sequence of human erythrocyte porphobilinogen deaminase. Nucleic Acids Res 91. Desnick RJ, Glass IA, Xu W, et al: Molecular genetics of congenital erythropoietic por-
14(15):5955, 1986. phyria. Semin Liver Dis 18(1):77, 1998.
58. Mignotte V, Eleouet JF, Raich N, et al: Cis- and trans-acting elements involved in the 92. Watson CJ, Perman V, Spurrell FA, et al: Some studies of the comparative biology
regulation of the erythroid promoter of the human porphobilinogen deaminase gene. of human and bovine porphyria erythropoietica. Trans Assoc Am Physicians 71:196,
Proc Natl Acad Sci U S A 86(17):6548, 1989. 1958.
59. Grandchamp B, Picat C, De Rooij FWM, et al: Molecular analysis of acute intermittent 93. Phillips JD, Steensma DP, Pulsipher MA, et al: Congenital erythropoietic porphyria
porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. due to a mutation in GATA1: The first trans-acting mutation causative for a human
Eur J Clin Invest 19:415, 1989. porphyria. Blood 109(6):2618, 2007.
60. Mathews MA, Schubert HL, Whitby FG, et al: Crystal structure of human uroporphy- 94. Seip M, Thune PO, Eriksen L: Treatment of photosensitivity in congenital erythropoi-
rinogen III synthase. EMBO J 20(21):5832, 2001. etic porphyria (CEP) with beta-carotene. Acta Derm Venereol 54(3):239, 1974.
61. Schubert HL, Phillips JD, Heroux A, et al: Structure and mechanistic implications of a 95. Haining RG, Cowger ML, Labbe RF, et al: Congenital erythropoietic porphyria. II. The
uroporphyrinogen III synthase-product complex. Biochemistry 47(33):8648, 2008. effects of induced polycythemia. Blood 36(3):297, 1970.
62. Phillips JD, Bergonia HA, Reilly CA, et al: A porphomethene inhibitor of uropor- 96. Piomelli S, Poh-Fitzpatrick MB, Seaman C, et al: Complete suppression of the symp-
phyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci U S A toms of congenital erythropoietic porphyria by long-term treatment with high-level
104(12):5079, 2007. transfusions. N Engl J Med 314(16):1029, 1986.
63. Smith AG, Clothier B, Robinson S, et al: Interaction between iron metabolism and 97. Guarini L, Piomelli S, Poh-Fitzpatrick MB: Hydroxyurea in congenital erythropoietic
2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: A hepatic porphyria [letter]. N Engl J Med 330:1091, 1994.
oxidative mechanism. Mol Pharmacol 53(1):52, 1998. 98. Pimstone NR, Gandhi SN, Mukerji SK: Therapeutic efficacy of oral charcoal in congen-
64. Romana M, Dubart A, Beaupain D, et al: Structure of the gene for human uroporphy- ital erythropoietic porphyria. N Engl J Med 316(7):390, 1987.
rinogen decarboxylase. Nucleic Acids Res 15(18):7343, 1987. 99. Hallai N, Anstey A, Mendelsohn S, et al: Pregnancy in a patient with congenital ery-
65. de Verneuil H, Grandchamp B, Foubert C, et al: Assignment of the gene for uropor- thropoietic porphyria. N Engl J Med 357(6):622, 2007.
phyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and 100. Dupuis-Girod S, Akkari V, Ged C, et al: Successful match-unrelated donor bone mar-
specific enzyme immunoassay. Hum Genet 66(2–3):202, 1984. row transplantation for congenital erythropoietic porphyria (Gunther disease). Eur J
66. Romeo PH, Raich N, Dubart A, et al: Molecular cloning and nucleotide sequence of a com- Pediatr 164(2):104, 2005.
plete human uroporphyrinogen decarboxylase cDNA. J Biol Chem 261(21):9825, 1986. 101. Geronimi F, Richard E, Lamrissi-Garcia I, et al: Lentivirus-mediated gene transfer of
67. Whitby FG, Phillips JD, Kushner JP, et al: Crystal structure of human uroporphyrino- uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
gen decarboxylase. EMBO J 17(9):2463, 1998. J Mol Med (Berl) 81(5):310, 2003.
68. Phillips JD, Whitby FG, Kushner JP, et al: Structural basis for tetrapyrrole coordination 102. Kauppinen R, Glass IA, Aizencang G, et al: Congenital erythropoietic porphyria: Pro-
by uroporphyrinogen decarboxylase. EMBO J 22(23):6225, 2003. longed high-level expression and correction of the heme biosynthetic defect by ret-
69. Rhee HW, Zou P, Udeshi ND, et al: Proteomic mapping of mitochondria in living cells roviral-mediated gene transfer into porphyric and erythroid cells. Mol Genet Metab
via spatially restricted enzymatic tagging. Science 339(6125):1328, 2013. 65(1):10, 1998.
70. Cacheux V, Martasek P, Fougerousse F, et al: Localization of the human coproporphy- 103. Holme SA, Anstey AV, Finlay AY, et al: Erythropoietic protoporphyria in the U.K.:
rinogen oxidase gene to chromosome band 3q12. Hum Genet 94(5):557, 1994. Clinical features and effect on quality of life. Br J Dermatol 155(3):574, 2006.
71. Kohno H, Furukawa T, Yoshinaga T, et al: Coproporphyrinogen oxidase. Purification, 104. Marko PB, Miljkovic J, Gorenjak M, et al: Erythropoietic protoporphyria patients in
molecular cloning, and induction of mRNA during erythroid differentiation. J Biol Slovenia. Acta Dermatovenerol Alp Pannonica Adriat 16(3):99, 104, 2007.
Chem 268(28):21359, 1993. 105. Parker M, Corrigall AV, Hift RJ, et al: Molecular characterization of erythropoietic
72. Takahashi S, Furuyama K, Kobayashi A, et al: Cloning of a coproporphyrinogen oxi- protoporphyria in South Africa. Br J Dermatol 159(1):182, 2008.
dase promoter regulatory element binding protein. Biochem Biophys Res Commun 106. Nakahashi Y, Fujita H, Taketani S, et al: The molecular defect of ferrochelatase in a
273(2):596, 2000. patient with erythropoietic protoporphyria. Proc Natl Acad Sci USA. 89(1):281-285,
73. Takahashi S, Taketani S, Akasaka JE, et al: Differential regulation of coproporphyrino- 192.
gen oxidase gene between erythroid and nonerythroid cells. Blood 92(9):3436, 1998. 107. Gouya L, Deybach JC, Lamoril J, et al: Modulation of the phenotype in dominant ery-
74. Conder LH, Woodard SI, Dailey HA: Multiple mechanisms for the regulation of haem thropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am
synthesis during erythroid cell differentiation. Possible role for coproporphyrinogen J Hum Genet 58(2):292, 1996.
oxidase. Biochem J 275(Pt 2):321, 1991. 108. Gouya L, Puy H, Lamoril J, et al: Inheritance in erythropoietic protoporphyria: A com-
75. Lamoril J, Deybach JC, Puy H, et al: Three novel mutations in the coproporphyrinogen mon wild-type ferrochelatase allelic variant with low expression accounts for clinical
oxidase gene. Hum Mutat 9(1):78, 1997. manifestation. Blood 93(6):2105, 1999.
76. Nishimura K, Taketani S, Inokuchi H: Cloning of a human cDNA for protoporphyrin- 109. Gouya L, Puy H, Robreau AM, et al: The penetrance of dominant erythropoietic pro-
ogen oxidase by complementation in vivo of a hemG mutant of Escherichia coli. J Biol toporphyria is modulated by expression of wildtype FECH. Nat Genet 30(1):27, 2002.
Chem 270(14):8076, 1995. 110. Gouya L, Martin-Schmitt C, Robreau AM, et al: Contribution of a common single-nu-
77. Taketani S, Inazawa J, Abe T, et al: The human protoporphyrinogen oxidase gene cleotide polymorphism to the genetic predisposition for erythropoietic protoporphy-
(PPOX): Organization and location to chromosome 1. Genomics 29(3):698, 1995. ria. Am J Hum Genet 78(1):2, 2006.
78. Koch M, Breithaupt C, Kiefersauer R, et al: Crystal structure of protoporphyrinogen 111. Holme SA, Whatley SD, Roberts AG, et al: Seasonal palmar keratoderma in erythro-
IX oxidase: A key enzyme in haem and chlorophyll biosynthesis. EMBO J 23(8):1720, poietic protoporphyria indicates autosomal recessive inheritance. J Invest Dermatol
2004. 129(3):599, 2009.
79. Morgan RR, Errington R, Elder GH: Identification of sequences required for the 112. Aplin C, Whatley SD, Thompson P, et al: Late-onset erythropoietic porphyria caused
import of human protoporphyrinogen oxidase to mitochondria. Biochem J 377(Pt by a chromosome 18q deletion in erythroid cells. J Invest Dermatol 117(6):1647, 2001.
2):281, 2004. 113. Shirota T, Yamamoto H, Hayashi S, et al: Myelodysplastic syndrome terminating in
80. de Vooght KM, van Wijk R, van Solinge WW: GATA-1 binding sites in exon 1 direct erythropoietic protoporphyria after 15 years of aplastic anemia. Int J Hematol 72(1):44,
erythroid-specific transcription of PPOX. Gene 409(1–2):83, 2008. 2000.

Kaushansky_chapter 58_p0889-0914.indd 910 9/18/15 5:58 PM